View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Durvalumab 1500 / Cisplatin 35 / Gemcitabine 1000, Bladder Cancer, neoadjuvant, cycle 1-4
Protocol-ID: 2720 V1.0 (Mini), DURV1500/CISP35/GEMC1000, Bladder Cancer, neoadj., C1-4Indication(s)
- Bladder Cancer; ICD-10 C67.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 08.10.2024